Putting Science to Work

In the News

Syngene International Q3 net profit up 11.54% at Rs 74 cr

Outlook-24/01/2017. We made good progress on client service delivery across all of business verticals despite a fire incident damaging one of our research facilities, effective implementation of our business continuity plan..

Discovery Chemistry Discovery Biology Safety Assessment Large Molecule Development Chemical Development Formulation Development Stability Studies Polymer Research Integrated Discovery & Development Clinical Development Services Bioinfomatics Antibody Drug Conjugates Oligonucleotide Synthesis Contact Us

This site is best viewed in Firefox (29+), Chrome (35+), or Microsoft Internet Explorer (9+)

Social Widget